Abstract:The high prevalence and great diversity of p53 tumor suppressor gene mutations in human tumors call for development of therapeutic molecules that rescue function of aberrant p53 protein. P53 mutations also offer new approaches to the study of the origins of mutations in human cancer. An experimental mouse model with a genetically modified but normal functioning p53 gene harboring the human rather than the murine core domain, would be of considerable benefit to research on both cancer therapeutics and etiology; however, it is uncertain whether such mice would permit biological functions of p53 to be retained. Using a Cre/lox P gene-targeting approach, we have constructed a hu man p 53 k nock- i n (hupki) mouse strain in which exons 4–9 of the endogenous mouse p53 allele were replaced with the homologous, normal human p53 gene sequence. The chimeric p53 allele (p53 KI ) is properly spliced, transcribed in various tissues at levels equivalent to wild-type mice, and yields cDNA with the anticipated sequence, that is, with a core domain matching that of humans. The hupki p53 protein binds to p53 consensus sequences in gel mobility shift assays and accumulates in the nucleus of hupki fibroblasts in response to UV irradiation, as is characteristic of wild-type p53. Induction of various p53-regulated genes in spleen of γ-irradiated homozygous hupki mice (p53 KI/KI ), and the kinetics of p53-dependent apoptosis in thymocytes are similar to results with wild-type (p53 +/+ ) mice, further indicating normal p53 pathway function in the hupki strain. The mice are phenotypically normal and do not develop spontaneous tumors at an early age, in contrast to knock-out (p53 −/− ) strains with a defective p53 gene. The chimeric (p53 KI ) allele thus appears to provide a biological equivalent to the endogenous murine (p53 + ) gene. This strain is a unique tool for examining in vivo spontaneous and induced mutations in human p53 gene sequences for comparison with published human tumor p53 mutation spectra. In addition, the hupki strain paves the way for mouse models in pre-clinical testing of pharmaceuticals designed to modulate DNA-binding activity of human p53.

Mup-knockout mice generated through CRISPR/Cas9-mediated deletion for use in urinary protein analysis

Major urinary protein (Mup) gene family deletion drives sex-specific alterations in the house-mouse gut microbiota

Generation and Phenotypic Analysis of Mice Lacking All Urea Transporters.

Zhx2 (zinc Fingers and Homeoboxes 2) Regulates Major Urinary Protein Gene Expression in the Mouse Liver

Establishment of Muc1 Gene Knockout Mouse Model

Characterization of Ayu17-449 Gene Expression and Resultant Kidney Pathology in a Knockout Mouse Model.

Deletion of the Uox gene generates a mouse model of hyperuricemia with cardiovascular complications

Generation and characterization of an inducible renal proximal tubule-specific CreERT2 mouse

CRISPR/Cas9 Mediated Deletion of the Uox Gene Generates a Mouse Model of Hyperuricemia with Multiple Complications

Abnormal Homeostasis of P53 Gene Knockout Mice Can Be Reflected in Urinary Proteome

Development and Characterization of MDR1 (Mdr1a/b) CRISPR/Cas9 Knockout Rat Model.

Precise and Rapid Validation of Candidate Gene by Allele Specific Knockout With CRISPR/Cas9 in Wild Mice

Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model.

Generation and Characterization of a TRIM21 Overexpressing Mouse Line

Generation and Phenotype of a Transgenic Knockout Mouse Lacking the Urea Transporters UT‐A2 and UT‐B

Spermatogenic Cell-Specific Gene Mutation in Mice Via CRISPR-Cas9.

Production of a Mouse Line with a Conditional Crim1 Mutant Allele

Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos

Generation of VDR Knock-Out Mice Via Zygote Injection of CRISPR/Cas9 System

Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool

Gene-deficient mouse model established by CRISPR/Cas9 system reveals 15 reproductive organ-enriched genes dispensable for male fertility